LORVIQUA
Iraq – Federal (Baghdad) Opposition closed
Some details of this record were read from an image by OCR. Check them against the official bulletin.
| Notice | Application |
|---|---|
| Application no. | 89231 |
| Filing date | 7 Aug 2022 |
| Nice classes | 5 |
| Owner | Pfizer Inc nd th |
| Address | 235 East 42Street, 9 Floor, New York, New York 10017, U.S.A |
| Country | United States |
| Bulletin | No. 1412, first announced 11 Sep 2023, last announced 25 Sep 2023, page 243 |
| Opposition deadline | 24 Dec 2023 (90 days from the last announcement; confirm with the office) |
| Official source | Open the official bulletin (PDF) |